Allergan, the makers of the Juvederm® family of facial dermal fillers, have 2 new fillers on the horizon for 2017. Both are temporary hyaluronic acid injectable fillers that use the patented Vycross™ technology from Allergan. Vycross™ technology allows for the Hylauronic Acid filler to be a soft and smooth product while combining blends of different molecular weights of hyaluronic acid. This blending of different molecular weights of hyaluronic acid contributes to the duration, or lasting effects, of the product. While both products contain Lidocaine to help minimize discomfort during treatment, the difference between Vollure and Volite is in the area that you treat and the expected outcomes of each product.
Juvederm® Vollure
Juvederm® Vollure is currently available in Europe under the name “Juvederm® Volift”. Allergan has rebranded it for the United States and will launch it as Juvederm® Vollure here. Vollure is a temporary facial filler that uses Allergan’s patented Vycross™ Technology. It will be used for the treatment of volume loss, facial contouring of the face and ‘static’ wrinkles in the nasolabial folds. In Europe, results for Vollure (Volift) can last up to 15 months. We assume we will see at least a 12 month approval, if not more, for the product here in the States when Vollure is finally FDA approved.
Juvederm® Volite
Juvederm® Volite is another new concept here in the US, using injectable HA to increase hydration, smoothness and elasticity of the skin. Volite can be used in the face, hands, neck and décolleté area. It is likely (depending on approval date) to be one of the 1st products on the market for the improvement of skin characteristics. Juvederm® Volite is injected to improve skin quality attributes. Sources say one treatment can last up to 6 months.
PS – Rumor has it that there is Voluma Plus in the works for the jawline. At this moment that’s all we have but we are excited for the possibility!
